Lupin announced the successful facility review carried out by Health Canada for its Pithampur Unit 2 (Indore) manufacturing facility. Following the review, Health Canada has maintained the compliant rating for Unit 2 at Pithampur (Indore) and has issued a revised 'Establishment License'.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
